-

06:57:11 PM

CPHI Stock News

CPHI - China Pharma Holdings Inc.

12/28/22 8:00 AM

AMEX : CPHI

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the launch of N95 medical

RHEA-AI

neutral

12/15/22 8:00 AM

AMEX : CPHI

covid-19

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its drugs were listed in The

RHEA-AI

neutral

12/05/22 8:00 AM

AMEX : CPHI

acquisition

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the Acquisition of Dry Eye Disease

RHEA-AI

neutral

12/02/22 4:10 PM

AMEX : CPHI

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on December 1, 2022, received a notification (the "Deficiency Letter") from the NYSE American LLC (the

RHEA-AI

negative

10/01/22 10:05 PM

AMEX : CPHI

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

China Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022, the Company received notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") informing it that the Company is not in

RHEA-AI

neutral

07/18/22 8:00 AM

AMEX : CPHI

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC ("NYSE American" or the

RHEA-AI

neutral

06/22/22 5:00 PM

AMEX : CPHI

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on June 15, 2022, the Company received a letter from NYSE American LLC ("NYSE American" or the

RHEA-AI

neutral

03/31/22 8:00 AM

AMEX : CPHI

earnings

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the fiscal

RHEA-AI

neutral

11/12/21 4:30 PM

AMEX : CPHI

earnings

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the

RHEA-AI

neutral

08/13/21 4:30 PM

AMEX : CPHI

earnings

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced the financial results for the

RHEA-AI

neutral

CPHI Data

IndustryPharmaceutical Preparation Manufacturing
Websitewww.chinapharmaholdings.com
CeoZhilin Li
Security nameChina Pharma Holdings Inc.
Issue typecs
SectorManufacturing
Sic code2834
Employees237
Tags
- Health Technology
- Pharmaceuticals: Generic
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Address2Nd Floor, No. 17, Jinpan Road
Address2Haikou
StateHainan
CityHaikou
Zip570216
CountryChina (Mainland)
Phone8689866811730

About China Pharma Holdings Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company that develops, manufactures and markets a diversified portfolio of products, focusing on conditions with high incidence and high mortality rates in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company’s wholly-owned subsidiary, Hainan Helpson Medical & Biotechnique Co., Ltd., is located in Haikou City, Hainan Province.